David M. O’Malley, MD, discusses the prognosis and historical treatment options for patients with platinum-agnostic ovarian cancer.
Posted in Apoptosis, Artificial Intelligence in CANCER, Biological Networks, Biological Networks, Gene Regulation and Evolution, Cancer - General, Cancer and Current Therapeutics, CANCER BIOLOGY & Innovations in Cancer Therapy, Cancer Screening, Cell Biology, Signaling & Cell Circuits, Computational Biology...
Five ovarian cancer treatments are being reviewed by UK health watchdog the National Institute for Health and Care Excellence (NICE) to ensure the NHS continues to offer the most cost-effective medicines to women. NICE is considering whether or not...Linda Banks...
Outline Highlights Abstract Graphical Abstract Keywords 1. Introduction 2. Ovarian cancer 3. Endometriosis 4. PCOS 5. Link among PCOS, endometriosis and ovarian cancer 6. Conclusion Author contributions Conflict of interest Acknowledgement References VitaeShow full outline Cited by (17) Figures (3)...
Nature Reviews Cancer volume 5, pages 355–366 (2005)Cite this article 7117 Accesses 450 Citations 3 Altmetric Metrics details Key Points The lethality of ovarian carcinoma primarily stems from the inability to detect the disease at an early, organ-confined stage, and the lack of effective ...
Targetovariancancer.org.uk Website Analysis: Domain Stats, IP Location & Safety Details We're the UK's leading ovarian cancer charity. We're here to support you, improve early diagnosis and fund life-saving ovarian cancer research. 922,613 ...
Nature Reviews Cancer (Nat Rev Cancer)ISSN1474-1768(online)ISSN1474-175X(print) Sign up for theNature Briefingnewsletter — what matters in science, free to your inbox daily. Email address Sign up I agree my information will be processed in accordance with theNatureand Springer Nature LimitedPr...
There have been major advances in our understanding of the cellular and molecular biology of the human malignancies that are collectively referred to as ovarian cancer. At a recent Helene Harris Memorial Trust meeting, an international group of researchers considered actions that should be taken to ...
However, relevant reviews and pooled analyses have some limitations as follows: first, some case–control or cohort studies include only women with moderate or severe endometriosis that thereby can overestimate ovarian cancer risk. Second, definite information about well-known preventive factors of ...
First-line platinum and taxane chemotherapy improves the prognosis of patients with epithelial ovarian cancer (EOC), however, about 80% of patients relapse and long-term survival is poor. The development of drug resistance is the main cause of treatment failure; therefore, the identification of new...